The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
3-Cyanophenyl 4-benzhydrylpiperidine-1-carboxylate ID: ALA4521157
PubChem CID: 118679385
Max Phase: Preclinical
Molecular Formula: C26H24N2O2
Molecular Weight: 396.49
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: N#Cc1cccc(OC(=O)N2CCC(C(c3ccccc3)c3ccccc3)CC2)c1
Standard InChI: InChI=1S/C26H24N2O2/c27-19-20-8-7-13-24(18-20)30-26(29)28-16-14-23(15-17-28)25(21-9-3-1-4-10-21)22-11-5-2-6-12-22/h1-13,18,23,25H,14-17H2
Standard InChI Key: GPWBPGWBQRHYDL-UHFFFAOYSA-N
Molfile:
RDKit 2D
30 33 0 0 0 0 0 0 0 0999 V2000
13.2387 -3.3183 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.2376 -4.1378 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.9456 -4.5468 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.6553 -4.1373 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.6525 -3.3147 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.9438 -2.9094 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3636 -4.5448 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0707 -4.1351 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.7735 -4.5459 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.4784 -4.1397 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.4814 -3.3222 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.7732 -2.9125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0621 -3.3204 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.1900 -2.9151 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.8968 -3.3253 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
18.1918 -2.0980 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
19.6054 -2.9183 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.3109 -3.3321 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.0191 -2.9258 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.0213 -2.1077 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.3095 -1.6977 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.6043 -2.1064 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.7226 -3.3326 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.4292 -3.7431 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.3652 -5.3610 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.6566 -5.7701 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.6575 -6.5866 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3664 -6.9949 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0758 -6.5808 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0714 -5.7657 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
4 7 1 0
7 8 1 0
8 9 1 0
8 13 1 0
9 10 1 0
10 11 1 0
11 12 1 0
12 13 1 0
11 14 1 0
14 15 1 0
14 16 2 0
15 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 17 1 0
23 24 3 0
19 23 1 0
25 26 2 0
26 27 1 0
27 28 2 0
28 29 1 0
29 30 2 0
30 25 1 0
7 25 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 396.49Molecular Weight (Monoisotopic): 396.1838AlogP: 5.60#Rotatable Bonds: 4Polar Surface Area: 53.33Molecular Species: ┄HBA: 3HBD: ┄#RO5 Violations: 1HBA (Lipinski): 4HBD (Lipinski): ┄#RO5 Violations (Lipinski): 1CX Acidic pKa: ┄CX Basic pKa: ┄CX LogP: 5.69CX LogD: 5.69Aromatic Rings: 3Heavy Atoms: 30QED Weighted: 0.58Np Likeness Score: -0.91
References 1. Alapafuja SO, Malamas MS, Shukla V, Zvonok A, Miller S, Daily L, Rajarshi G, Miyabe CY, Chandrashekhar H, Wood J, Tyukhtenko S, Straiker A, Makriyannis A.. (2019) Synthesis and evaluation of potent and selective MGL inhibitors as a glaucoma treatment., 27 (1): [PMID:30446439 ] [10.1016/j.bmc.2018.11.003 ]